Literature DB >> 11098082

Seven genes that are differentially transcribed in colorectal tumor cell lines.

I Nimmrich1, S Erdmann, U Melchers, U Finke, S Hentsch, M P Moyer, I Hoffmann, O Müller.   

Abstract

To identify genes which are differentially transcribed in colorectal tumor cells, we compared the two human tumor cell lines, SW480 and HCT116, with the cell line, NCM460, from normal colon epithelium as a control. Using the methods of differential display reverse transcription PCR and Northern blot hybridization, we detected the differential transcription of seven genes: cholecystokinin, reticulocalbin, Rab5 guanine nucleotide exchange factor Rabex5, caldesmon, differentiation related gene 1 (drg1), taxol resistant associated gene 3 (Trag-3) and the gene for the placental protein, diff33. The yet unidentified cDNA of the human Rabex5 gene and the 3' untranslated region of the human caldesmon gene were cloned.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098082     DOI: 10.1016/s0304-3835(00)00553-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.

Authors:  Fuliang Zhang; Meng Zhang; Guohua Hu; Qiling Cai; Tongbai Xu
Journal:  Tumour Biol       Date:  2015-05-23

2.  Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray.

Authors:  Zhi-Jun Tan; Xian-Gui Hu; Gui-Song Cao; Yan Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients.

Authors:  Verena Materna; Paweł Surowiak; Irina Kaplenko; Merek Spaczyński; Zhenfeng Duan; Maciej Zabel; Manfred Dietel; Hermann Lage
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

Review 4.  Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges.

Authors:  Anil Suri; Nirmala Jagadish; Shikha Saini; Namita Gupta
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

5.  Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.

Authors:  D Ding; H Huang; W Jiang; W Yu; H Zhu; J Liu; H Saiyin; J Wu; H Huang; S Jiang; L Yu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

6.  Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.

Authors:  Gang Wang; Qian Wang; Yongguo Fan; Xianli He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  Calumenin but not reticulocalbin forms a Ca2+-dependent complex with thrombospondin-1. A potential role in haemostasis and thrombosis.

Authors:  Gry Aune Westergaard Hansen; Henrik Vorum; Christian Jacobsen; Bent Honoré
Journal:  Mol Cell Biochem       Date:  2008-08-08       Impact factor: 3.396

8.  Elevated RABEX-5 expression predicts poor prognosis in non-small-cell lung cancer.

Authors:  Fuliang Zhang; Yingjie Jia; Fanming Kong; Guohua Hu; Qiling Cai; Tongbai Xu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

9.  Salivary NUS1 and RCN1 Levels as Biomarkers for Oral Squamous Cell Carcinoma Diagnosis.

Authors:  Sei Ueda; Kengo Hashimoto; Satoru Miyabe; Shogo Hasegawa; Mitsuo Goto; Dai Shimizu; Ichiro Oh-Iwa; Kazuo Shimozato; Toru Nagao; Shuji Nomoto
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.

Authors:  Xiang Zhang; Jie Min; Yingjian Wang; Yan Li; Hongzhong Li; Qiang Liu; Xinjie Liang; Peng Mu; Hongyuan Li
Journal:  J Exp Clin Cancer Res       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.